Finance
Pharmaceutical company announces execution of equity financing
Published in Biotech Business Week, August 23rd, 2004
Under the terms of the funding agreements with Cornell Capital Partners, LP, a New Jersey-based domestic investment fund, Provectus has obtained $750,000 in Convertible Securities and a firm commitment of $20 million under a Standby Equity Distribution Agreement. Provectus may, at its discretion, issue shares to Cornell at any time over the next 2 years.
The maximum aggregate amount of the equity placements pursuant to the agreement is $20 million. Subject to this limitation, Provectus may...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Anthrax
Company awarded NIH grant to develop anthrax vaccine - Collaborations
Target & marker discovery collaboration with Merck to focus on AD - HIV Prevention
Anti-HIV protein evolved millions of years before AIDS emergence - HIV/AIDS
HIV vaccine candidate into human clinical trials - Peripheral Vascular Disease
Clinical trial initiated for a drug-eluting non-coronary stent - Addiction Medicine
Adolescent substance abuse counseling service contract awarded - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
